August 20, 2015 – On August 18, 2015, the PTAB granted Musculoskeletal Transplant Foundation’s petition requesting an inter partes review of U.S. Patent No. 8,372,437 (“the ’437 Patent”) related to a method for preparing placenta membrane tissue grafts. The PTAB concluded that the Petition established a reasonable likelihood that Petitioner would prevail in showing that claims 1 and 2 of the ’437 Patent are unpatentable as obvious under 35 U.S.C. § 103(a). The case is captioned Musculoskeletal Transplant Foundation v. MiMedx Group, Inc., IPR2015-00664.
By: Ketan V. Patel